Answers are grounded in this paper and cite their sources.
Finerenone is a nonsteroidal mineralocorticoid receptor antagonist, which is used to retard the progression of chronic kidney disease in persons with type 2 diabetes. This communication describes the various aspects of patient counseling needed to ensure safe and effective usage of the molecule. It utilizes the 5C checklist: Confirmation of clinical indication; Caveats and contraindications; Concerns and checkpoints; Caution and use with concomitant medication; and Constraints and cost, to create a simple, yet comprehensive tool for clinical use.
No takes yet. Share an insight, caveat, or question.
Kalra et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: